BNP Paribas Financial Markets
CLOV icon

BNP Paribas Financial Markets’s Clover Health Investments CLOV Stock Holding History

BNP Paribas Financial Markets’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Sell
68,640
-21,697
-24% -$73.7K ﹤0.01% 3934
2026
Q1 		$159K Sell
90,337
-53
-0.1% -$115 ﹤0.01% 4151
2025
Q4 		$212K Buy
90,390
+11,855
+15% +$32.4K ﹤0.01% 4031
2025
Q3 		$240K Buy
78,535
+43,884
+127% +$125K ﹤0.01% 3922
2025
Q2 		$96.7K Sell
34,651
-5,586
-14% -$18.4K ﹤0.01% 4029
2025
Q1 		$144K Sell
40,237
-251,499
-86% -$1.01M ﹤0.01% 3888
2024
Q4 		$919K Buy
+291,736
New +$1.04M ﹤0.01% 2884

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BNP Paribas Financial Markets's CLOV Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Clover Health Investments (CLOV) stake by 24% in Q2 2026, selling an estimated $73.7K and leaving 68,640 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #3934.

BNP Paribas Financial Markets first reported a position in CLOV in Q4 2024 and has held it in 7 quarters since. The position peaked at $919K in Q4 2024. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • BNP Paribas Financial Markets held 68,640 shares of Clover Health Investments worth $360K as of Q2 2026.
  • BNP Paribas Financial Markets sold 21,697 Clover Health Investments shares in Q2 2026, an estimated $73.7K.
  • Clover Health Investments made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3934 holding.
  • BNP Paribas Financial Markets first reported a position in Clover Health Investments in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Clover Health Investments position peaked at $919K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.